Mark J Tarr insider trades: Encompass Health (EHC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | EHC | ↓ Sell | 173,148 | $125.47 | $21.7M | Direct | Aug 11, 2026 (1d) |
| Feb 11, 2026 | EHC | ↓ Sell | 150,000 | $111.64 | $16.7M | Direct | Feb 12, 2026 (1d) |
| May 20, 2025 | EHC | ↓ Sell | 118,384 | $121.53 | $14.4M | Direct | May 20, 2025 (0d) |
| Apr 30, 2024 | EHC | ↓ Sell | 44,976 | $83.27 | $3.7M | Direct | May 1, 2024 (1d) |
| Aug 16, 2023 | EHC | ↓ Sell | 25,330 | $71.06 | $1.8M | Direct | Aug 17, 2023 (1d) |
| Aug 17, 2022 | EHC | ↓ Sell | 20,449 | $53.25 | $1.1M | Direct | Aug 19, 2022 (2d) |
| May 14, 2020 | EHC | ↓ Sell | 26,132 | $61.92 | $1.6M | Direct | May 14, 2020 (0d) |
| May 1, 2019 | EHC | ↓ Sell | 67,382 | $63.56 | $4.3M | Direct | May 3, 2019 (2d) |
| May 1, 2018 | EHC | ↓ Sell | 33,100 | $60.96 | $2.0M | Direct | May 2, 2018 (1d) |
| Aug 7, 2017 | HLS | ↓ Sell | 22,625 | $43.00 | $973K | Direct | Aug 8, 2017 (1d) |
| Aug 3, 2017 | HLS | ↓ Sell | 22,625 | $42.55 | $963K | Direct | Aug 4, 2017 (1d) |
| Nov 9, 2016 | HLS | ↑ Buy | 6,371 | $39.29 | $250K | Direct | Nov 14, 2016 (5d) |
| Aug 2, 2016 | HLS | ↓ Sell | 20,000 | $41.85 | $837K | Direct | Aug 3, 2016 (1d) |
| Feb 27, 2015 | HLS | ↓ Sell | 11,000 | $43.82 | $482K | Direct | Mar 2, 2015 (3d) |
| Nov 14, 2013 | HLS | ↓ Sell | 11,000 | $35.27 | $388K | Direct | Nov 15, 2013 (1d) |
| Aug 2, 2012 | HLS | ↓ Sell | 8,000 | $22.25 | $178K | Direct | Aug 3, 2012 (1d) |
| Aug 14, 2007 | HLS | ↑ Buy | 8,600 | $17.31 | $149K | Direct | Aug 14, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EHC insiders
Open-market trades in the last 12 months
About Mark J Tarr's insider trades
Mark J Tarr is President & CEO at Encompass Health (EHC). Since Aug 14, 2007, Mark has reported 2 open-market purchases worth $399K and 15 sales worth $71.2M on SEC Form 4. In the last 12 months: 2 sales ($38.5M).
Their filings also include shares withheld for taxes (49 filings), grants and awards (40 filings), option exercises (15 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.